Ewha Womans University Mokdong Hospital
Seoul, 07985, South Korea
NCT Number: NCT04994639
It is a single-center randomized controlled trial that aims to figure out the effect of the hypotension prediction index (HPI) on the prevention of acute kidney injury (AKI) after radical cystectomy. The primary hypothesis is that HPI software guidance prevents postoperative AKI by reducing the duration and severity of intraoperative hypotension (IOH).
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Seoul, 07985, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The hemodynamic condition of the HPI group will be managed by HPI guidance which is derived by arterial pressure waveform information, including Eadyn, SVV, dP/dt.
Time frame: Seven day after the operation
Occurrence of acute kidney injury after radical cystectomy
Time frame: From applying HPI (hypotension prediction index) monitor to the arterial line to the end of the anesthesia
Depth and duration of hypotension will be assessed by calculating time weighted average (TWA) of hypotension under mean arterial pressure under 65 mmHg during the operation
Time frame: From applying HPI (hypotension prediction index) monitor to the arterial line to the end of the anesthesia
Time weighted average of hypotension prediction index during the operation
Ewha Womans University Mokdong Hospital
Other
Effect of Use of Hypotension Prediction System in Prevention of Postoperative Acute Kidney Injury in Radical Cystectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03924856
Bladder Cancer, Female Urogenital Diseases
La Jolla, California, United States
View Trial DetailsNCT04081246
Bladder Cancer, Bladder Neoplasm
Hong Kong
View Trial DetailsNCT05512377
Biliary Tract Cancer, Biliary Tract Diseases
Mobile, Alabama, United States
View Trial DetailsNCT06955910
Behavior, Behavioral Symptoms
Padova, Italy/Padova, Italy
View Trial Details